Product Information
METHYLPHENIDATE ER 15 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $2.6482 per EA under NDC 00591386219. Its NADAC has been published 96 times since Apr 17, 2024.
Strength
15 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591386219
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208861On Market Since
9/30/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 15 MG CAP has been published 96 times since Apr 17, 2024, and over the history we have for it it has declined 41.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6482 per EA |
|---|---|
| All-time high | $4.5612 (May 15, 2024) |
| All-time low | $2.4861 (Jul 17, 2024) |
| 52-week high | $2.6482 |
| 52-week low | $2.6482 |
| Median price | $2.6482 |
| Average price | $2.7585 |
| Largest weekly change | -29.5% (May 22, 2024) |
| Weeks tracked | 96 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 15 MG CAP, manufactured by Actavis Pharma, Inc., is $2.6482 per EA (NDC 00591386219), effective Feb 11, 2026.
How has the price of METHYLPHENIDATE ER 15 MG CAP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 15 MG CAP has declined 41.9%. It has been tracked across 96 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 15 MG CAP?
Since Apr 17, 2024, the NADAC for METHYLPHENIDATE ER 15 MG CAP has ranged from a low of $2.4861 (Jul 17, 2024) to a high of $4.5612 (May 15, 2024), with a median of $2.6482 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 15 MG CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as METHYLPHENIDATE ER 15 MG CAP, but none are currently priced below it.
Who manufactures METHYLPHENIDATE ER 15 MG CAP?
METHYLPHENIDATE ER 15 MG CAP (NDC 00591386219) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification